AOL Money & Finance

LCAPA posts

Feed

Disney's 'A Christmas Carol' didn't die off in second weekend

Last week, I discussed my disappointment with Disney's (DIS) A Christmas Carol. As a shareholder of the Mouse, I remain dissatisfied with the performance. However, this past weekend's theatrical take of the film makes me a little happier.

According to early estimates at Box Office Mojo, Carol scored about $22 million at domestic theaters, making it the second most popular film of the three-day period. Sure, it wasn't number one, but given the fact that Carol made $30 million last weekend, I'd say you have to give it some credit for avoiding a significant percentage drop. So far, it has generated more than $60 million in revenue.

Continue reading Disney's 'A Christmas Carol' didn't die off in second weekend

Disney's 'A Christmas Carol': Investors not in a merry mood?

Disney (DIS) had high hopes for A Christmas Carol. It was supposed to be an unqualified blockbuster. Unfortunately, the film's first weekend at the box office was nothing short of a disaster.

Too strong? Hardly. According to early estimates at Box Office Mojo, Carol took in little more than $30 million at domestic screenings. It was wasn't supposed to be like this. Carol was supposed to be light-years ahead of the competition. Sony's (SNE) Michael Jackson's This Is It came in second. The Men Who Stare at Goats, distributed by Liberty Capital Group's (LCAPA) Overture Films, was third. And The Fourth Kind, from General Electric's (GE) Universal, is currently ranked, aptly enough, in fourth place. Each of the latter three pictures had a gross of somewhere between $12 million and $14 million. To me, Carol's take didn't seem as disproportionate as it should have been.

Continue reading Disney's 'A Christmas Carol': Investors not in a merry mood?

Viacom's 'Paranormal Activity' continues to wow Hollywood

Time Warner's (NYSE: TWX) Where the Wild Things Are was number one over the past weekend at domestic theaters as of early estimates from Box Office Mojo. The film grossed well over $30 million. Coming in second was Law Abiding Citizen. If Wild Things wasn't in the market this weekend, that one definitely would have been tops at the multiplex. The revenge fest, from Liberty Capital Group's (NASDAQ: LCAPA) Overture Films, brought in $21 million.

Right on the heels of that project is the very cheaply made Paranormal Activity, courtesy of Viacom (NYSE: VIA). It made about $20 million. So far, Activity has generated over $30 million in total. And they say the little horror extravaganza cost less than $20,000 to produce!

Continue reading Viacom's 'Paranormal Activity' continues to wow Hollywood

Analyst upgrades, downgrades and initiations: GOOG, HOG, NOK, SWY, WAG, WSM ...

Analyst upgrades:

  • Keefe Bruyette upgraded Intercontinental Exchange (NYSE: ICE) to Outperform from Market Perform on expectations that derivatives trading will increase in the coming quarters.
  • NutriSystem (NASDAQ: NTRI) was upgraded to Buy from Neutral by Janney Montgomery, which believes that the company's earnings have hit bottom, while the company could report better-than-expected Q1 results.
  • Harley-Davidson (NYSE: HOG) was upgraded to Outperform from Sector Perform at RBC Capital. The firm thinks the company is an early-cycle story that has significant upside potential.
  • UBS upgraded Walgreen (NYSE: WAG) to Buy from Neutral citing cost cutting efforts and slowing store growth.
  • Google (NASDAQ: GOOG) was upgraded to Buy from Hold at Benchmark Co.
  • Safeway (NYSE: SWY) was upgraded to Buy from Hold by BB&T.
  • Needham upgraded Targacept (NASDAQ: TRGT) to Buy from Hold.
  • Sierra Wireless (NASDAQ: SWIR) was raised to Buy from Hold at Jesup & Lamont.

Continue reading Analyst upgrades, downgrades and initiations: GOOG, HOG, NOK, SWY, WAG, WSM ...

Analyst upgrades, downgrades and initiations: HMSY, TSO, CTX, HOG, BBY, NOC, TWX

Analyst upgrades:
  • Jefferies upgraded HMS Holdings (NASDAQ: HMSY) to Buy from Hold on valuation as they believe the recent weakness provides an attractive entry point. The firm keeps a $36 price target on shares.
  • Credit Suisse believes Universal Health (NYSE: UHS) is well positioned to gain market share, that earnings risk from the Las Vegas market is manageable, and that the balance sheet provides flexibility. The firm upgraded shares to Outperform from Neutral and raised their target to $48 from $46.
  • UBS upgraded RF Micro (NASDAQ: RFMD) to Buy from Neutral citing checks that indicate strengthening momentum, impact from recent restructuring, and expected debt reduction. The analyst raised RFMD estimates above consensus and upped the price target to $3 from $1.10.
  • Liberty Capital (NASDAQ: LCAPA) was upgraded to Buy from Hold at Deutsche Bank.
  • Tesoro (NYSE: TSO) was raised to Hold from Sell at Soleil.
  • SunTrust (NYSE: STI) was lifted at Keefe Bruyette to Outperform from Market Perform.

Continue reading Analyst upgrades, downgrades and initiations: HMSY, TSO, CTX, HOG, BBY, NOC, TWX

Analyst calls: CNB, ERIC, ASML, TRMB, BCS, DISCA, JNS, RGEN, GPS and NTY

Analyst upgrades:
  • Keefe Bruyette upgraded shares of Colonial Bancgroup (NYSE: CNB) to Outperform from Market Perform on valuation following the recent weakness and believes the company will be eligible to receive TARP funds. Morgan Stanley believes the company's valuation adequately reflects risk to the loan portfolio; the firm raised shares to Equal Weight from Underweight.
  • Merrill upgraded Ericsson (NASDAQ: ERIC) and ASML Holding (NASDAQ: ASML) to Buy from Underperform and believes their valuation reflects the worst-case for bad news.
  • Oppenheimer upgraded Trimble Navigation to Outperform from Perform on valuation as they believe the company's long-term growth story is intact.
  • Celestica (NYSE: CLS) was upgraded to Sector Outperformer from Sector Performer at CIBC.
  • KeyCorp (NYSE: KEY) was added to Goldman's Conviction Buy List.
  • Wachovia raised EastGroup Properties (NYSE: EGP) to Outperform from Market Perform.
Analyst downgrades:
  • UBS cut Barclays (NYSE: BCS) to Neutral from Buy as they believe capital raises could negatively impact earnings and that the dividend is likely to be cut.
  • JP Morgan downgraded Discovery Holdings (NASDAQ: DISCA) to Underweight from Neutral based on valuation and the deteriorating economic outlook.
  • Friedman Billings downgraded shares of Janus Capital (NYSE: JNS) to Underperform from Market Perform and lowered its target to $7 from $23 as they see further risk to the downside following the company's weaker-than-expected results.
  • LKQ Corp (NASDAQ: LKQX) was cut to Sector Perform from Outperform at RBC Capital.
  • Affymetrix (NASDAQ: AFFX) was lowered to Sell from Hold at Deutsche Bank.
  • RightNow Tech (NASDAQ: RNOW) was downgraded at Baird to Neutral from Outperform.

Continue reading Analyst calls: CNB, ERIC, ASML, TRMB, BCS, DISCA, JNS, RGEN, GPS and NTY

Will Liberty and EarthLink compete for AOL's dial-up unit?

FT.com reports that Liberty Media Corp (NASDAQ: LCAPA) and EarthLink (NASDAQ: ELNK) may enter the bidding for AOL's dial-up internet access operation (which shares a parent, Time Warner (NYSE: TWX), with BloggingStocks). Liberty thinks its advantage is its ability to do a "tax efficient transaction."

Meanwhile Liberty's stake in Time Warner is worth just slightly more than the price tag Time Warner has placed on AOL's dial up unit. As FT.com wrote, "Liberty Media's 103m shareholding in Time Warner was valued at $1.64bn last night, slightly above analysts' $1.5bn valuation of AOL's access business."

Liberty's interest is new but industry analysts have seen EarthLink as "the only likely strategic buyer for AOL's dial-up business." FT.com notes that Rolla Huff, EarthLink's CEO, "told the Wall Street Journal this month that a deal for AOL's access business was something 'worth aggressively pursuing'."

Continue reading Will Liberty and EarthLink compete for AOL's dial-up unit?

Newspaper wrap-up: Wachovia to announce capital infusion as soon as Monday

MAJOR PAPERS:
  • Wachovia Corporation (NYSE: WB) could announce a capital infusion of several billion dollars from outside investors as early as Monday, people familiar with the matter said. While final terms of the deal are still being worked on, the Wall Street Journal reported that the bank is expected to receive between $6B-$7B, in return the investor group would receive shares priced at roughly $23-$24 per share.
  • According to people familiar with the matter, the Wall Street Journal reported that Deutsche Bank AG (NYSE: DB) is seeking to sell as much as $20B in debt to a 'collection of investors,' which include private-equity firms.
OTHER PAPERS:

Barry Diller wins (IACI)

Barry Diller has won his dispute with John Malone. Malone's Liberty Media (NASDAQ: LCAPA) owns a a large piece of the company that Diller runs, IAC/Interactive (NASDAQ: IACI). Diller has the right to vote those shares under a long-standing agreement.

Diller has decided to break IACI into five companies because the businesses in the firm do not have significant relationships to one another. Malone wanted to block the break-up and filed suit in court.

According to MarketWatch, "Vice Chancellor Stephen Lamb ruled Friday that "Liberty has failed to demonstrate that Diller has breached or threatened to breach any contractual duty he owes to Liberty," according to Lamb's 78-page opinion."

Diller can now complete his plans.

That leaves open the question of whether IACI is worth more in pieces than it is as a conglomerate. The firm's stock trades at $20, near its 52-week low and down from the period high of over $39. Some of the company's divisions, especially Lending Tree and HSN had tough years in 2007. These would get very low valuations as independent operations and might not make up for the value of more attractive operations like Ask.com

Diller may have gotten his way, but it is not clear that it will help shareholders.

Douglas A. McIntyre is an editor at 247wallst.com.

Newspaper wrap-up: Investor group expected to announce raised stake in New York Times

MAJOR PAPERS:
  • According to people familiar with the matter, the Wall Street Journal reported that an investor group that includes Harbinger Capital Partners is expected to report a raised stake in The New York Times Company (NYSE: NYT). The raised stake is expected to be close to matching the 19% stake owned by the Sulzberger family.
  • The Goldman Sachs Group Inc (NYSE: GS) has been spared many of the problems of the subprime mortgage crisis, but other areas where it's involved, such as investment banking and leveraged loans, are hurting the firms profitability, the Wall Street Journal reported.
OTHER PAPERS:
  • Cablevision Systems Corporation (NYSE: CVC) is seeking to put a valuation on its Rainbow Media unit, in order to possibly sell it, sources say. In the past, the unit, which consists of several cable channels, has been valued at $3B, but the Dolan family is hoping to obtain a higher price, according to the New York Post. Possible buyers include Liberty Media Corporation (NASDAQ: LCAPA) and News Corporation (NYSE: NWS).
  • Elan Corporation (NYSE: ELN) is considering splitting its biopharmaceuticals arm, which markets Tysabri, from its drug technology division, the Sunday Times noted. The potential spin-off could unlock up to $1.5B to share holders.

Analyst upgrades: TWX, MDTH and SLB

MOST NOTEWORTHY: Time Warner, MedCath and Schlumberger were today's noteworthy upgrades:
  • UBS upgraded shares of Time Warner (NYSE: TWX) to Buy from Neutral on valuation and believes the company's focus on structural improvements and cost reductions will provide positive catalysts.
  • MedCath (NASDAQ: MDTH) was upgraded to Outperform from Market Perform at Wachovia, as they view weakness following the Q1 miss due to a higher-than-expected option expense as a buying opportunity.
  • Bear Stearns raised Schlumberger (NYSE: SLB) to Outperform from Peer Perform, as they believe the company is well-positioned for the next oilfield service business cycle and valuation.
OTHER UPGRADES:

Analyst initiations: OXPS, SUPX and SYT

MOST NOTEWORTHY: OptionXpress Holdings, Supertex and Syngenta were today's noteworthy initiations:
  • Merriman believes OptionXpress Holdings (NASDAQ: OXPS) has lost market share, and remains vulnerable on many fronts. They expect the competitive landscape will continue to intensify, pressuring margins and growth rates. The firm initiated shares with a Sell rating.
  • Morgan Keegan started Supertex (NASDAQ: SUPX) with a Market Perform rating, citing lack of near-term catalysts.
  • Syngenta (NYSE: SYT) was initiated with an Outperform rating at Bear, as they are positive on the company's defensive growth profile and valuation.
OTHER INITIATIONS:
  • HSBC initiated FedEx (NYSE: FDX) with a Neutral rating and $102 target and United Parcel Service (NYSE: UPS) with an Overweight rating and $86 target.
  • Credit Suisse started Liberty Media (NASDAQ: LCAPA) with an Outperform rating and $140 target.

Newspaper wrap-up: Potential crackdowns forced Countrywide to seek out Bank of America

MAJOR PAPERS:
OTHER PAPERS:
  • Shares of Britain's third-largest drug maker, Shire Plc (NASDAQ: SHPGY) plummeted yesterday to a two-year low on concerns about demand for its attention deficit hyperactivity disorder treatment for children, Vyvanse, the Telegraph reported.

Newspaper wrap-up: IBM-AMD merger rumor is 'speculation gone amok'

MAJOR PAPERS:
  • Liberty Media Corporation (NASDAQ: LCAPA) filed a lawsuit in Delaware against IAC/InterActiveCorp's (NASDAQ: IACI) Barry Diller in an attempt to block Mr. Diller from completing the spinoffs of several units on terms that could dilute Liberty's voting power; the suit follows a suit filed by IAC against Liberty seeking to complete the divestiture on its own terms, the Wall Street Journal said.
OTHER PAPERS:
  • The Evening Standard learned that billionaire Wilbur Ross is in takeover talks with AMBAC Financial Group Inc (NYSE: ABK) and that a deal could come within the next two weeks.
WEB SITES:

Analyst initiations: WX, MYGN, CYPB and KNOL

MOST NOTEWORTHY: Aerospace stocks, WuXi Pharma, Myriad Genetics, Cypress Bioscience and Knology were today's noteworthy initiations:
  • LYON initiated shares of aerospace stocks including Goodrich Corporation (NYSE: GR), TransDigm Group Inc (NYSE: TDG) and Triumph Group Incorporated (NYSE: TGI) with Add ratings and a $74 target, $45 target and $90 target, respectively.
  • WuXi Pharmatech (NYSE: WX) was started with a Hold rating and $29 target at Jefferies on valuation. JP Morgan started shares with a Neutral rating and Credit Suisse initiated shares with an Outperform rating.
  • Myriad Genetics Inc (NASDAQ: MYGN) was started with a Hold rating and $50 target at Citigroup, as the firm is cautious on the Phase III Flurizan results and does not recommend putting new money here at these levels.
  • Citigroup also initiated shares of Cypress Biosciences Inc (NASDAQ: CYPB) with a Buy rating and $22 target as the firm believes Milnacipran has sufficient database for approval and is capable of gaining meaningful market share as firstline therapy.
  • Knology Inc (NASDAQ: KNOL) was initiated with a Buy rating and $25 target at BWS Financial, as the firm believes the company's growth potential is greater than other cable companies through a business plan that allows it to have operations in all regions of the U.S.
OTHER INITIATIONS:

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA-17.2410,433.71
NASDAQ-6.832,169.18
S&P 500-0.591,105.65

Last updated: November 25, 2009: 12:17 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance